SPECIAL REPORT
MOST SHARED
- We're Not Greece: Italian Prime Minister Monti
- Obama Likely to Call for Cutting Top Corporate Tax Rate
- To Play Senate Cybersecurity Bill, Cramer Likes Fortinet Stock
- Greek Cabinet Approves EU, IMF Bailout Bill
- Special Feature: Wall Street History - How Wall Street Got Its Name
- How to Trade the Turmoil in Greece
- Private Homebuilders: Dead Men Walking
- Why Cramer Likes Select Comfort Over Tempur-pedic Stock
- Cramer: 10 Earnings to Watch Next Week
- Lightning Round: Trina Solar, Zoltek, Affymax and More
- In Search of America's ‘Hottest Forecasters’
- Dow vs. S&P 500: Which is a Better Investment?
- Mick Fleetwood on the MP3 ‘Dumbing Down’ of Music
- Avis on the Road to Strong Growth: Analyst
- Private Homebuilders: Dead Men Walking
- LinkedIn’s Growth Is Already Priced In: Analyst
- The Real Reason Behind Bank of America’s Rally
- 5 Hedge Funds’ Top Stocks Soar After 2011 Rout
- This Valentine’s Day Love Is Served on a Silver Platter
- Greek Cabinet Approves EU, IMF Bailout Bill
- We're Not Greece: Italian Prime Minister Monti
- Private Homebuilders in the US: Dead Men Walking
- Dividend Payout Could Hit Record Amount This Year
- With Investors So Bullish, Stock Pullback Must Be Ahead
- Obama Likely to Call for Cutting Top Corporate Tax Rate
- New York Fashion Week Fall 2012
- NetNet: Why Saving Greece Could Destroy the World
- My Funny Valentine: When Love and the Fed Collide
RSS FEED
Pharma's Market
Text Size 
Merck's Marketing Challenge: Gardasil For Guys
(Disclaimer: This blog entry contains sexually explicit information.)
 |
How in the world is Merck gonna rebrand a product it has spent so much time, effort and money gearing toward females so that males will use it, too?
I'm not sure, but it'll be interesting to watch if or when MRK wins Food and Drug Administration approval of Gardasil for boys/young men.
This morning the company announced positive results from a big test of the vaccine on males. Gardasil is a $300-$400 set of three shots given over six months to prevent HPV, the most common sexually transmitted disease, which is the leading cause of cervical cancer.
But males carry and spread the virus, which can also cause other types of cancer (i.e. anal, penile and oral) that are less common than cervical cancer, but can be every bit as serious. Merck [MRK
Loading...
()
] says it plans to file for FDA approval of Gardasil for males by the end of this year. If all goes smoothly, the company could get the agency's go ahead around the middle or second half of 2009. Many analysts think it could reinvigorate sales growth of Gardasil which is, nonetheless, a blockbuster. But, again, I come back to the question of how Madison Avenue will sell it.
Gardasil for females has sparked a significant amount of social debate and controversy—i.e. critics say it promotes promiscuity, that vaccination should be up to the parents of underage children and not mandated by schools or governments and others have tried to stir up worries about the vaccine's safety. Recently, the Centers for Disease Control said there's no evidence the shots are harmful.
Here, Merck will face the challenge of convincing parents of minor males that Gardasil's worth the expense to prevent their kid(s) from getting genital warts, a very rare form of cancer and from spreading a virus to others (a chivalrous/common-good reason?). And I can just hear the schoolyard comments like, "Gardasil's for girls!", or "Gardasil's for gay guys!" HPV is a big issue for sexually active gay and bisexual men. But Dr. Howard Grossman at the Fenway Community Health Clinic in Boston told me that HPV is also a significant concern for straight men who he said are using (according to a recent study, in surprising numbers) anal sex toys.
In the third quarter Merck sold more than $400 million worth of Gardasil. But the company acknowledges it's been having trouble convincing young women between the ages of 19 and 26 to get the shots. Earlier this week, during lunch at a Cleveland Clinic conference, I was sitting at a table with an OB GYN who is an outspoken proponent of Gardasil. She mentioned a startling anecdote to a few of us sitting within earshot that she has encountered female patients around 20 years old who said their pediatricians had told them there was no need to get the vaccine because they'd be virgins when they got married.
Merck has its work cut out for it.
More from Pharma's Market
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
